Support for Human Specimen Banking in Nci-Supported Cancer Clinical Trials
The summary for the Support for Human Specimen Banking in Nci-Supported Cancer Clinical Trials grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Support for Human Specimen Banking in Nci-Supported Cancer Clinical Trials: The purpose of this initiative is to support the infrastructure needed to ensure the collection of, storage of, and access to high-quality, well- annotated human specimens collected from and representative of the patient populations entered into NCI-funded, phase III clinical treatment trials. The advent of powerful molecular technologies and the emergence of targeted therapeutics have opened the door to developing more effective and, in some cases, individualized treatment of patients with cancer. Access to specimens with associated high-quality clinical, treatment, recurrence, and outcome data will be critical to developing and validating the tests needed for diagnosis, target identification, and prediction of response to therapy. Developing and effectively using cancer interventions based on the comprehensive analysis of critical pathways of cancer initiation and progression will ultimately require access to specimens from patients treated in prospective randomized trials. High quality banks of uniformly collected specimens with validated clinical and outcome data will be essential for development and delivery of the new diagnostic and predictive tools that are critical to eliminating the suffering and death due to cancer by 2015. Groups organizing and carrying out phase III clinical trials are uniquely positioned to provide the high quality specimens and have the informative clinical data and resources needed to meet this challenging goal.
| Federal Grant Title: | Support for Human Specimen Banking in Nci-Supported Cancer Clinical Trials |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Health Education |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-CA-05-017 |
| Type of Funding: | Cooperative Agreement |
| CFDA Numbers: | 93.39493.395 |
| CFDA Descriptions: | Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Jul 21, 2004 |
| Posted Date: | May 03, 2004 |
| Creation Date: | May 03, 2004 |
| Archive Date: | Oct 14, 2004 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | $1,500,000 |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster